Kaiser Permanente Northern California

Does Kaiser Permanente Northern California cover Zepbound?

Quick answer · Weight Loss

Kaiser Permanente Northern California covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance.

  • Employer / Commercial Insurance: Covered with requirements. BMI of 30 or higher

Last verified June 5, 2026. Policy effective June 1, 2026. Source: Standard-Commercial-Guidelines-6-1-26-EXCERPTED.pdf. How we verify this data →

Check your card for your exact plan →

Zepbound for Weight Loss

What Kaiser Permanente Northern California requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (HTN, T2DM, dyslipidemia, CVD, CAD, OSA, osteoarthritis of the knee, polycystic ovarian syndrome, NASH/NAFLD, asthma, and COPD)
  • BMI of 27.5 or higher for patients of Asian descent
  • 6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Initial approval — BMI >= 30 kg/m2 (non-Asian)

All of:

  • Age 18 or older
  • BMI >= 30 kg/m2
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Initial approval — Asian patient BMI >= 27.5 kg/m2

All of:

  • Age 18 or older
  • Asian patient with BMI >= 27.5 kg/m2
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Initial approval — BMI >= 27 kg/m2 with comorbidity (non-Asian)

All of:

  • Age 18 or older
  • BMI >= 27 kg/m2
  • At least one weight-related comorbidity (hypertension, T2DM, dyslipidemia, cardiovascular disease, CAD, sleep apnea, osteoarthritis of the knee, polycystic ovarian syndrome, NASH/NAFLD, asthma, COPD)
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Initial approval — Asian patient BMI >= 25 kg/m2 with comorbidity

All of:

  • Age 18 or older
  • Asian patient with BMI >= 25 kg/m2
  • At least one weight-related comorbidity (hypertension, T2DM, dyslipidemia, cardiovascular disease, CAD, sleep apnea, osteoarthritis of the knee, polycystic ovarian syndrome, NASH/NAFLD, asthma, COPD)
  • Actively enrolled in exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Documentation to bring

  • Baseline BMI documentation (>= 30 kg/m2, or >= 27.5 kg/m2 for Asian patients, or >= 27 kg/m2 with comorbidity, or >= 25 kg/m2 for Asian patients with comorbidity)
  • Documentation of at least one weight-related comorbidity if using lower BMI threshold pathway
  • Documentation of active enrollment in exercise and caloric reduction program
  • Confirmation that Zepbound will not be used concurrently with a GLP-1 receptor agonist
  • At renewal: documentation of at least 5% weight loss from baseline body weight

Approval and renewal

  • To renew, the plan looks for at least 5% weight loss from the starting weight and Patient must have achieved or maintained at least 5% weight loss from baseline (pre-treatment) body weight. BMI eligibility thresholds are re-verified at renewal (same thresholds as initial). Age and lifestyle program enrollment requirements from initial criteria are not explicitly re-verified at renewal. Concurrent GLP-1 use remains prohibited. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Concurrent use of a GLP-1 receptor agonist (liraglutide, semaglutide, exenatide, exenatide extended-release)

Policy note: For Asian patients, the BMI threshold without comorbidity is 27.5 kg/m2 and with comorbidity is 25 kg/m2. For non-Asian patients, BMI threshold without comorbidity is 30 kg/m2 and with comorbidity is 27 kg/m2. At renewal, the BMI eligibility thresholds are re-verified using the same criteria as initial approval, plus the 5% weight loss requirement. The lifestyle program enrollment and age requirement are present in initial criteria but not explicitly listed in renewal criteria.

Policy effective June 1, 2026 · verified June 5, 2026 · source: Standard-Commercial-Guidelines-6-1-26-EXCERPTED.pdf

Zepbound for Osa

What Kaiser Permanente Northern California requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27.5 or higher for patients of Asian descent
  • 6 months of a documented diet and exercise program
  • Diagnosed obstructive sleep apnea (AHI of 15 or higher), with a documented trial of PAP therapy

Qualification pathways

You can qualify through any one of these.

Initial approval for moderate to severe OSA

All of:

  • Diagnosis of moderate to severe obstructive sleep apnea
  • AHI/RDI/REI of at least 15 events per hour, predominantly obstructive
  • Age 18 or older
  • Actively enrolled in an exercise and caloric reduction program
  • Not using Zepbound concurrently with a GLP-1 receptor agonist

Plus any one of:

  • BMI >= 30 kg/m2
  • Asian patient with BMI >= 27.5 kg/m2

Initial OSA approval — PAP therapy condition

All of:

  • All other OSA initial criteria met

Plus any one of:

  • Persistent OSA symptoms despite PAP adherence (at least 4 hours per night on at least 70% of nights)
  • Clinical documentation that patient is not a candidate for PAP
  • Clinical documentation that patient is intolerant of PAP

Documentation to bring

  • Documentation of moderate to severe OSA diagnosis
  • AHI/RDI/REI result showing >= 15 events per hour that is predominantly obstructive
  • Documentation of BMI >= 30 kg/m2 (or >= 27.5 kg/m2 for Asian patients)
  • Documentation of active enrollment in exercise and caloric reduction program
  • Documentation of persistent OSA symptoms despite PAP adherence (>=4 hours/night on >=70% of nights) OR clinical documentation of ineligibility or intolerance to PAP
  • Confirmation that Zepbound will not be used concurrently with a GLP-1 receptor agonist

Approval and renewal

  • To renew, the plan looks for Patient must have achieved or maintained a reduction in AHI/RDI/REI by at least 15 events per hour OR by at least 50%. Concurrent GLP-1 receptor agonist use remains prohibited at renewal.

Not covered when

  • Concurrent use of a GLP-1 receptor agonist (liraglutide, semaglutide, exenatide, exenatide extended-release)

Policy note: OSA must be predominantly obstructive. PAP adherence is defined as at least 4 hours per night on at least 70% of nights. At renewal, AHI/RDI/REI must be reduced by at least 15 events per hour OR by at least 50% from baseline. Age and lifestyle program enrollment requirements from initial criteria are not explicitly re-verified at renewal per the renewal criteria text; only the AHI/RDI/REI improvement and no concurrent GLP-1 use are listed as renewal requirements.

Policy effective June 1, 2026 · verified June 5, 2026 · source: Standard-Commercial-Guidelines-6-1-26-EXCERPTED.pdf

Why Zepbound requests get denied by Kaiser Permanente Northern California

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
  2. BMI not documented in the chart notes (or documented without a baseline weight and date).
  3. Qualifying weight-related condition not documented with its own diagnosis code.
  4. No documented diet and exercise program.
  5. Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

Frequently asked questions

Does Kaiser Permanente Northern California cover Zepbound?
Kaiser Permanente Northern California covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance.
What BMI do you need for Zepbound under Kaiser Permanente Northern California?
For weight loss on Employer / Commercial Insurance plans, Kaiser Permanente Northern California requires a BMI of 30 or higher, or 27 or higher with a qualifying weight-related condition.
What does Kaiser Permanente Northern California require to renew Zepbound?
At least 5% weight loss from the starting weight and Patient must have achieved or maintained at least 5% weight loss from baseline (pre-treatment) body weight. BMI eligibility thresholds are re-verified at renewal (same thresholds as initial). Age and lifestyle program enrollment requirements from initial criteria are not explicitly re-verified at renewal. Concurrent GLP-1 use remains prohibited.
How current is this information?
This page reflects Kaiser Permanente Northern California's written policy as of June 1, 2026, last verified against the source document on June 5, 2026.

Other medications under Kaiser Permanente Northern California

Zepbound coverage under other plans

All insurance plans · All medications

This page summarizes Kaiser Permanente Northern California's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.